HMG-CoA reductase inhibitors may affect thrombin generation by reducing factor VII activity in hyperlipidemic patients

被引：2
|
作者：
Ural, A. Ugur [1 ]
Avcu, Ferit
机构：
[1] Gulhane Mil Med Acad, Dept Hematol, Ankara, Turkey
[2] Gulhane Mil Med Acad, Canc Res Ctr, Ankara, Turkey
[3] Gulhane Mil Med Acad, Dept Med & Canc Res Ctr, Ankara, Turkey
[4] Gulhane Mil Med Acad, Sch Med, Dept Hematol, TR-06010 Ankara, Turkey
来源：
THROMBOSIS RESEARCH | 2006年 / 118卷 / 05期
关键词：
D O I：
10.1016/j.thromres.2005.11.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：665 / 666
页数：2
相关论文
共 50 条
  • [21] Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease
    Hilleman, DE
    Wurdeman, RL
    Lenz, TL
    PHARMACOTHERAPY, 2001, 21 (04): : 410 - 415
  • [22] Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors
    Langone, AJ
    Chuang, P
    TRANSPLANTATION, 2006, 81 (05) : 804 - 807
  • [23] Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients
    Martin, Jill E.
    Cavanaugh, Teresa M.
    Trumbull, Leslie
    Bass, Maryetta
    Weber, Fredrick, Jr.
    Aranda-Michel, Jaime
    Hanaway, Michael
    Rudich, Steven
    CLINICAL TRANSPLANTATION, 2008, 22 (01) : 113 - 119
  • [24] Dual effects of HMG-CoA reductase inhibitors on vascular endothelial growth factor synthesis
    Frick, M
    Dulak, J
    Zwick, R
    Alber, H
    Dichtl, W
    Schwarzacher, SR
    Pachinger, O
    Weidinger, F
    EUROPEAN HEART JOURNAL, 2002, 23 : 422 - 422
  • [25] Coadministration of HMG-CoA reductase inhibitors, atorvastatin and rosuvastatin, does not affect contraceptive efficacy of centchroman
    Sharma, Abhisheak
    Jaiswal, Swati
    Shukla, Mahendra
    Ravindrachary, Kondagudur
    Lal, Jawahar
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2015, 20 (03): : 231 - 235
  • [26] Effects of HMG-CoA reductase inhibitors on vascular endothelial ecto-nucleotidase activity
    Matsuoka, Isao
    Ito, Masaaki
    Yomogida, Shinichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 82P - 82P
  • [27] The impact of tissue selectivity on the anti-atherosclerotic activity of HMG-CoA reductase inhibitors
    Roth, BD
    CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (01) : 139 - 154
  • [28] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF INDAZOLE-DERIVED HMG-COA REDUCTASE INHIBITORS
    KIM, JI
    JAHNG, YD
    ARCHIVES OF PHARMACAL RESEARCH, 1995, 18 (03) : 206 - 212
  • [29] HMG-CoA Reductase Inhibitors and the Modification of Risk for Disseminated Intravascular Coagulation in Patients with Sepsis
    Ciurylo, William
    BLOOD, 2022, 140 : 11370 - 11370
  • [30] HMG-CoA reductase inhibitors and the attenuation of risk for disseminated intravascular coagulation in patients with sepsis
    Alana, Nicholas B.
    Ciurylo, William A.
    Hurlock, Natalie
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (02) : 260 - 268
12345